Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01526291 · ClinicalTrials.gov registry record
Patient-Reported Outcomes With LASIK:PROWL-1
A clinical trial, sponsored by Food and Drug Administration (FDA).
- Completed
- Registry status
- 550
- Enrollment target
NCT01526291 is a clinical trial that has completed, run by Food and Drug Administration (FDA). The registered enrollment target is 550 participants.
The verdict
NCT01526291 has completed, sponsored by Food and Drug Administration (FDA).
- COMPLETED
- Registry status
- 550 participants
- Enrollment target
Study Summary
This study evaluates a questionnaire designed to measure satisfaction and ophthalmic-related quality of life (QOL)in up to 550 active duty subjects prior to and six months following state-of-the-art laser in situ keratomileusis (LASIK).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2011-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01526291
The ClinicalTrials.gov registry entry for NCT01526291 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 550 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Food and Drug Administration (FDA), which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01526291 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01526291 about?
NCT01526291 is a clinical study titled "Patient-Reported Outcomes With LASIK:PROWL-1". This study evaluates a questionnaire designed to measure satisfaction and ophthalmic-related quality of life (QOL)in up to 550 active duty subjects prior to and six months following state-of-the-art laser in situ keratomileusis (LASIK).
What is the current status of trial NCT01526291?
This trial is currently completed. The enrollment target is 550 participants. The study started on 2011-08.
Who is sponsoring clinical trial NCT01526291?
This trial is sponsored by Food and Drug Administration (FDA), which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.